Liraglutide(Progenity)

N/A

Report date: 2022/04/13 13:30:18

Base Information

Drug NameLiraglutide(Progenity)
Drug Alias NamePGNOB-2PGN-OB2
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Cardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProgenity Inc
China Registration ClassN/A

Develop Information

Active CompaniesProgenity Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Cardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A